| TTM
|
11/30/2025
|
11/30/2024
|
11/30/2023
|
11/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-93.8230 | -151.5860 | -126.2240 | -201.3600 | -295.6930 |
|
Exploration Expenses
|
-- | -- | -- | 49.2400 | 0 |
| Other Income/Expense, Operating
|
-289.1570 | -286.8950 | -350.9580 | -33.2780 | -227.1740 |
|
Operating Income/Expenses
|
-382.9800 | -438.4810 | -477.1820 | -234.6380 | -522.8670 |
|
Total Operating Profit/Loss
|
-382.9800 | -438.4810 | -477.1820 | -234.6380 | -522.8670 |
| Total Net Finance Income/Expense
|
-22.9040 | -22.9030 | -22.9030 | -22.9030 | 0 |
| Irregular Income/Expenses
|
-106.1680 | -116.1680 | -7.2150 | 1.3700 | -314.5650 |
|
Other Income/Expense, Non-Operating
|
0 | 0 | 15.4070 | 0 | 46.8650 |
|
Non-Operating Income/Expenses, Total
|
-129.0720 | -139.0710 | -14.7110 | -21.5330 | -267.7000 |
|
Pretax Income
|
-512.0520 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
|
Net Income from Continuing Operations
|
-512.0520 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-512.0520 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
|
Net Income after Non-Controlling/Minority Interests
|
-512.0500 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
|
Net Income Available to Common Stockholders
|
-512.0500 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
|
Diluted Net Income Available to Common Stockholders
|
-512.0500 | -577.5520 | -491.8930 | -256.1710 | -790.5670 |
| Basic EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Diluted EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
|
Basic Weighted Average Shares Outstanding
|
104,577.2020 | 84,169.0380 | 48,237.6300 | 45,871.8270 | 40,087.5310 |
|
Diluted Weighted Average Shares Outstanding
|
104,577.2020 | 84,169.0380 | 48,237.6300 | 45,871.8270 | 40,087.5310 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-489.1480 | -554.6490 | -468.9900 | -233.2680 | -790.5670 |
|
EBITDA
|
-489.1480 | -554.6490 | -468.9900 | -233.2680 | -790.5670 |
|
Normalized EBITDA
|
-382.9800 | -438.4810 | -461.7750 | -234.6380 | -476.0020 |
|
Normalized Income
|
-405.8840 | -438.4810 | -477.1820 | -257.5410 | -476.0020 |
|
Total Unusual Items
|
106.1680 | 116.1680 | 7.2150 | -1.3700 | 314.5650 |
|
Total Unusual Items Excluding Goodwill
|
106.1680 | 116.1680 | 7.2150 | -1.3700 | 314.5650 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11/30/2022 - 11/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade